Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Simulations Plus, Inc.NASDAQ: SLP

Financing Cash Flow · Q2 FY2026 · quarter ended Feb 2026

Financing cash flow turns positive

Q2 FY2026 financing cash flow was $474K, compared with -$1.55M a year earlier. Trailing-twelve-month financing cash flow was $590K. Over 3 fiscal years it compounded at -46.8% a year.

Context

  • Financing cash flow amounted to 1.4% of revenue in FY2025, down 7.9 pp from a year earlier.
  • Financing cash flow grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near $474K or moves back toward the trailing-twelve-month quarterly average of $147.5K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$474K+23600.0% QoQ
Last fiscal yearAug 2025
-$1.15M-82.5% YoY
LTMFeb 2026
$590K+110.3% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+130.6%——
1 year-82.5%——
3-year CAGR-46.8%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(1.15M) USD
Year-over-year change
+82.5%

Financing Cash Flow vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +110.3% is the 6th highest of 11, against a peer median of +105.8%.
  • Financing cash flow amounts to 0.7% of revenue for SLP, versus a peer median of 25.5%.
SLP Competitors
Financing Cash Flow for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NAKANakamoto Inc.LTM Mar 2026$723.38M USD+13967.7%+995.9%18455.2%
ANROAlto Neuroscience, Inc.LTM Mar 2026$165.89M USD+1517.0%+11.1%—
KRROKorro Bio, Inc.LTM Mar 2026$88.73M USD+27.9%+236.4%2309.3%
DHDefinitive Healthcare Corp.LTM Mar 2026$51.96M USD-65.2%+78.1%21.8%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$46.34M USD+308.7%—57.1%
CLLSCellectis S.A.LTM Mar 2026$17.39M USD-123.8%—25.5%
NRCNational Research CorporationLTM Mar 2026$17.39M USD+86.9%-34.2%12.5%
OPRXOptimizeRx CorporationLTM Mar 2026$10.92M USD+124.8%-22.6%10.2%
AGLAgilon Health, Inc.LTM Mar 2026$7.98M USD+141.6%—0.1%
ACIUAC Immune S.A.LTM Dec 2025CHF 1.02M CHF-9.0%-10.2%28.5%
SLPSimulations Plus, Inc.LTM Feb 2026$590K USD+110.3%-46.8%0.7%
Peer median (excluding SLP) —+105.8%+11.1%25.5%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Net Income9.78M12.48M9.96M9.95M(64.72M)
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
Deferred Income Tax(628K)(270K)(2.1M)(1.77M)(5.43M)
Stock-Based Compensation2.75M3.04M4.83M6.54M6.35M
Change in Working Capital974K(2.62M)5.1M(4.21M)(2.59M)
Accounts Receivables(2.43M)(3.94M)4.1M3.13M(581K)
Inventory3.15M0000
Accounts Payables39K(162K)(81K)(477K)(132K)
Other Working Capital210K1.48M1.09M(6.86M)(1.87M)
Other Non-Cash Items2.74M1.7M219K(2.86M)76.29M
Operating Cash Flow19.2M17.9M21.86M13.32M18.13M
Capital Expenditures(4.58M)(3.97M)(4.27M)(566K)(713K)
Acquisitions (Net)2.95M3.15M(8.22M)(98.77M)0
Purchases of Investments(122.4M)(100.85M)(95.05M)(67.16M)(6.5M)
Sales of Investments100.23M109.12M114.91M116.27M15.01M
Other Investing Activities(2.95M)(3.15M)(3.82M)(3.74M)(4.24M)
Investing Cash Flow(26.74M)4.31M7.37M(53.97M)3.56M
Debt Repayment00000
Common Stock Issued1.46M891K0731K430K
Common Stock Repurchased00(20M)00
Dividends Paid(4.81M)(4.85M)(4.81M)(4.8M)0
Other Financing Activities(1.33M)(3.67M)1.54M(2.5M)(1.58M)
Financing Cash Flow(4.68M)(7.62M)(23.27M)(6.57M)(1.15M)
Effect of Forex Changes00000
Net Change in Cash(12.22M)14.58M5.96M(47.21M)20.54M
Free Cash Flow14.63M13.93M17.58M12.75M17.41M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.